The Digital Source For China's Tech Innovation Since 2000

Week In Review: BeiGene Completes $3.5 Billion IPO On Shanghai STAR Board | Markets

December 19, 2021

Source:

News Snapshot:

BeiGene, a Beijing oncology company, began trading on the Shanghai STAR Board as the last step in its $3.5 billion IPO. The company is now listed in the US, Hong Kong, and Shanghai.

Go To Original Source →

Other Related News:

PET scans reveal early signs of Parkinson’s and Lewy body disorders

April 29, 2025

‘Source of data’: are electric cars vulnerable to cyber spies and hackers?

April 29, 2025

Simple urine sample could revolutionize early prostate cancer diagnosis

April 29, 2025

China uses 'gravitational slingshots' to save 2 satellites that were stuck in the wrong orbit for 123 days

April 29, 2025

Donald Trump, beware – this is what a global liberal fightback looks like

April 28, 2025

The 5 most exciting new EVs from the Shanghai Auto Show 2025 that could launch globally

April 28, 2025

Revealed: online campaign urged far right to attack China’s opponents in UK

April 28, 2025

MG Cyberster GTS coupe heading to Australia

April 28, 2025

Chinese factories stop production, eye new markets as U.S. tariffs hit

April 28, 2025